The Patent Finder

Peptide Therapeutics Limited

Also on record
Records under this name other than patents Peptide Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Peptide Therapeutics Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,326,917Scanner-control device
Formerly held
Term ended
Term ended May 15, 2020 · USPTO record
Term endedTerm ended May 15, 2020USPTO record
US 6,034,066Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases
Formerly held
Term ended
Term ended Feb 26, 2018 · USPTO record
Term endedTerm ended Feb 26, 2018USPTO record
US 6,902,906Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines
Formerly held
Lapsed on the fee record
Ended Jun 7, 2017 · USPTO record
Lapsed on the fee recordEnded Jun 7, 2017USPTO record
US 6,528,275Substrates and inhibitors of proteolytic enzymes
Formerly held
Lapsed on the fee record
Ended Mar 4, 2015 · USPTO record
Lapsed on the fee recordEnded Mar 4, 2015USPTO record
US 6,372,885Solid-phase technology for the preparation of amides
Formerly held
Lapsed on the fee record
Ended Apr 16, 2014 · USPTO record
Lapsed on the fee recordEnded Apr 16, 2014USPTO record
US 6,680,182Expression of recombinant fusion proteins in attenuated bacteria
Formerly held
Lapsed on the fee record
Ended Jan 20, 2012 · USPTO record
Lapsed on the fee recordEnded Jan 20, 2012USPTO record
US 7,169,399Non-toxic double mutant forms of pertussis toxin as adjuvants
Formerly held
Lapsed on the fee record
Ended Jan 30, 2011 · USPTO record
Lapsed on the fee recordEnded Jan 30, 2011USPTO record
US 5,601,821Immunoactive peptides and antibodies and their use in anti-allergy treatment
Term ended
Term ended no later than Feb 11, 2017 · Low confidence
Term endedTerm ended no later than Feb 11, 2017Low confidence
US 5,827,668Immunodiagnostic assay for rheumatoid arthritis
Term ended
Term ended no later than Oct 27, 2018 · Low confidence
Term endedTerm ended no later than Oct 27, 2018Low confidence
US 5,837,686Peptides and antibodies for treatment of rheumatoid arthritis
Term ended
Term ended no later than Nov 17, 2018 · Low confidence
Term endedTerm ended no later than Nov 17, 2018Low confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited